NEW YORK, Oct. 31 – Three executives at Celera Genomics, including the company’s chief operating officer, have left the company in the past five weeks, GenomeWeb has learned. 

Peter Chambre, former COO, has left the firm for Applera, Celera’s parent company. Heather Kowalski, a Celera spokeswoman, said he will be working with Tony White, Applera’s chairman, president, and CEO. 

A title for the former COO has not yet been determined, according to his secretary, and it was not immediately clear who will replace him at Celera.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.